Alain Charrier
About Alain Charrier
Alain Charrier serves as the Head of Industrial Performance at Laboratoire Aguettant, where he has worked since 2018. With over two decades of experience in the pharmaceutical sector, he specializes in enhancing industrial performance in the manufacturing of injectable drugs.
Work at Laboratoire Aguettant
Alain Charrier has held multiple roles at Laboratoire Aguettant, a prominent player in the pharmaceutical industry. He began his tenure as Responsable De Site - Plant Manager from 1996 to 2010, where he managed plant operations for 14 years. Following this role, he served as Responsable Ingénierie - Head of Engineering from 2010 to 2017, focusing on engineering aspects within the company. Since 2018, he has been the Responsable Performance Industrielle - Head of Industrial Performance, concentrating on enhancing industrial performance, particularly in the manufacturing of injectable drugs.
Education and Expertise
Alain Charrier possesses a strong educational background in management and engineering. He studied at Cesi Ecole D'ingénieurs from 1992 to 1994, where he gained foundational engineering knowledge. He furthered his education at Iaelyon School of Management, achieving a Master's degree from 2003 to 2004. His expertise lies in industrial performance management within the pharmaceutical sector, with a specific focus on improving operational efficiency in drug manufacturing.
Background
Alain Charrier has a long-standing career in the pharmaceutical industry, primarily with Laboratoire Aguettant. His journey began in 1996 and has spanned over two decades, during which he has taken on various leadership roles. His experience encompasses both plant management and engineering, allowing him to develop a comprehensive understanding of industrial operations and performance.
Achievements
Throughout his career at Laboratoire Aguettant, Alain Charrier has been instrumental in enhancing the operational efficiency of the group's factories. His focus on maintaining and improving industrial performance has contributed to the successful manufacturing of injectable drugs, aligning with the company's goals in the pharmaceutical sector.